Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cytochrome P450 reductase | 0.0187 | 0.0654 | 0.0654 |
Loa Loa (eye worm) | hypothetical protein | 0.0544 | 0.3142 | 0.3032 |
Echinococcus granulosus | zinc finger protein Ran binding | 0.0544 | 0.3142 | 0.3032 |
Schistosoma mansoni | RNA binding protein | 0.0544 | 0.3142 | 0.3142 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0187 | 0.0654 | 0.0156 |
Schistosoma mansoni | zinc finger protein | 0.0544 | 0.3142 | 0.3142 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0544 | 0.3142 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0544 | 0.3142 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.1529 | 1 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0544 | 0.3142 | 0.3032 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0544 | 0.3142 | 0.3032 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0544 | 0.3142 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0544 | 0.3142 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0544 | 0.3142 | 0.3032 |
Toxoplasma gondii | ran binding protein | 0.0544 | 0.3142 | 0.3142 |
Echinococcus multilocularis | tumor protein p63 | 0.1417 | 0.9222 | 0.921 |
Echinococcus granulosus | tumor protein p63 | 0.1417 | 0.9222 | 0.921 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1529 | 1 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.1529 | 1 | 1 |
Brugia malayi | YY1-associated factor 2 | 0.0544 | 0.3142 | 0.3032 |
Loa Loa (eye worm) | hypothetical protein | 0.0207 | 0.08 | 0.0652 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0187 | 0.0654 | 0.056 |
Echinococcus granulosus | Zinc finger RanBP2 type | 0.0544 | 0.3142 | 0.3032 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1529 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0187 | 0.0654 | 0.0505 |
Plasmodium vivax | hypothetical protein, conserved | 0.1529 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0544 | 0.3142 | 1 |
Giardia lamblia | Hypothetical protein | 0.0165 | 0.0507 | 0.5 |
Echinococcus granulosus | ring and YY1 binding protein | 0.0544 | 0.3142 | 0.3032 |
Echinococcus multilocularis | ring and YY1 binding protein | 0.0544 | 0.3142 | 0.3032 |
Leishmania major | p450 reductase, putative | 0.0187 | 0.0654 | 0.056 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1529 | 1 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0207 | 0.08 | 0.08 |
Loa Loa (eye worm) | brahma associated protein | 0.1529 | 1 | 1 |
Echinococcus multilocularis | Nuclear pore complex protein Nup153 | 0.0544 | 0.3142 | 0.3032 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Chlamydia trachomatis | SWIB complex protein | 0.1529 | 1 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0544 | 0.3142 | 0.3032 |
Onchocerca volvulus | 0.0544 | 0.3142 | 0.2546 | |
Schistosoma mansoni | fusion | 0.0544 | 0.3142 | 0.3142 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0165 | 0.0507 | 0.5 |
Onchocerca volvulus | 0.1529 | 1 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.1529 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0544 | 0.3142 | 0.3142 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0187 | 0.0654 | 0.0505 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0544 | 0.3142 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0544 | 0.3142 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1529 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1529 | 1 | 1 |
Echinococcus multilocularis | Zinc finger, RanBP2 type | 0.0544 | 0.3142 | 0.3032 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0544 | 0.3142 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0187 | 0.0654 | 0.5 |
Plasmodium falciparum | zinc finger Ran-binding domain-containing protein 2, putative | 0.0544 | 0.3142 | 0.2662 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0544 | 0.3142 | 1 |
Onchocerca volvulus | Ubiquitin thioesterase ZRANB1 homolog | 0.0544 | 0.3142 | 0.2546 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0187 | 0.0654 | 0.0505 |
Schistosoma mansoni | hypothetical protein | 0.1529 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1529 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.1529 | 1 | 1 |
Onchocerca volvulus | 0.0544 | 0.3142 | 0.2546 | |
Leishmania major | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0187 | 0.0654 | 0.0505 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0187 | 0.0654 | 0.0505 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0094 | 0.001 | 0.001 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.0544 | 0.3142 | 0.3142 |
Onchocerca volvulus | 0.0544 | 0.3142 | 0.2546 | |
Brugia malayi | flavodoxin family protein | 0.0187 | 0.0654 | 0.0505 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.1529 | 1 | 1 |
Toxoplasma gondii | Zn-finger in Ran binding protein and others domain-containing protein | 0.0544 | 0.3142 | 0.3142 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0187 | 0.0654 | 0.0505 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.1529 | 1 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.1529 | 1 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.1529 | 1 | 1 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.1529 | 1 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0187 | 0.0654 | 0.0156 |
Onchocerca volvulus | 0.0544 | 0.3142 | 0.2546 | |
Loa Loa (eye worm) | hypothetical protein | 0.0187 | 0.0654 | 0.0505 |
Echinococcus granulosus | Nuclear pore complex protein Nup153 | 0.0544 | 0.3142 | 0.3032 |
Loa Loa (eye worm) | hypothetical protein | 0.0544 | 0.3142 | 0.3032 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.1529 | 1 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0544 | 0.3142 | 0.3032 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0544 | 0.3142 | 0.3032 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.1529 | 1 | 1 |
Echinococcus multilocularis | zinc finger protein Ran binding | 0.0544 | 0.3142 | 0.3032 |
Loa Loa (eye worm) | hypothetical protein | 0.0544 | 0.3142 | 0.3032 |
Leishmania major | hypothetical protein, conserved | 0.0544 | 0.3142 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0115 | 0.0158 | 0.0158 |
Brugia malayi | brahma associated protein 60 kDa | 0.1529 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1529 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Growth inhibition (functional) | = 20 % | An vitro anti-leishmanial activity against Leishmania donovani promastigotes (25 microM) | ChEMBL. | No reference |
Growth inhibition (functional) | = 20 % | An vitro anti-leishmanial activity against Leishmania donovani promastigotes (25 microM) | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Antifungal activity against Aspergillus fumigatus (AF-27) | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Antifungal activity against Candida albicans (SKF) | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Atifungal activity against Cryptococcus neoformans (CN-17) | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | In vitro for antifungal activity against Sporothrix schenck ii (SS-1) | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | In vitro for antifungal activity against Trichophyton mentagrophytes (A-280) | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Antifungal activity against Candida albicans (SKF) | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Atifungal activity against Cryptococcus neoformans (CN-17) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.